Teva Pharmaceutical The Global Leader in Affordable Medicine Under 25
TEVA Stock | USD 16.96 0.02 0.12% |
About 55% of Teva Pharma's investors are presently thinking to get in. The analysis of overall sentiment of trading Teva Pharma Industries stock suggests that some investors are interested at this time. The current market sentiment, together with Teva Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharma Industries stock news signals to limit their universe of possible portfolio assets.
We recently published a list of 12 Best Stocks Under 25 To Invest In Right Now. In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited stands against other best stocks under 25 to invest in right now. A View of the US Stock Market Post-Election As reported
Read at finance.yahoo.com
![]() |
Teva Pharma Industries Current Investor Sentiment
Comfort Level 55
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Teva Pharma's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Teva Pharma Industries.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Teva Pharma Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Teva Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Teva Pharma Industries Historical Investor Sentiment
Investor biases related to Teva Pharma's public news can be used to forecast risks associated with an investment in Teva. The trend in average sentiment can be used to explain how an investor holding Teva can time the market purely based on public headlines and social activities around Teva Pharma Industries. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Teva Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Teva Pharma and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Teva Pharma news discussions. The higher the estimate score, the more favorable the investor's outlook on Teva Pharma.
Teva Pharma Maximum Pain Price Across July 18th 2025 Option Contracts
Teva Pharma's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Teva Pharma close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Teva Pharma's options.
Teva Pharma Fundamental Analysis
We analyze Teva Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Teva Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Teva Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Teva Pharma is currently under evaluation in target price category among its peers.
Teva Pharma Industries Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Teva Pharma stock to make a market-neutral strategy. Peer analysis of Teva Pharma could also be used in its relative valuation, which is a method of valuing Teva Pharma by comparing valuation metrics with similar companies.
Peers
Teva Pharma Related Equities
TAK | Takeda Pharmaceutical | 1.11 | ||||
LFCR | Lifecore Biomedical | 0.75 | ||||
HLN | Haleon Plc | 0.72 | ||||
ZTS | Zoetis | 0.38 | ||||
ACB | Aurora Cannabis | 0.18 | ||||
ELAN | Elanco Animal | 0.08 | ||||
CRON | Cronos | 0.98 | ||||
VTRS | Viatris | 1.07 | ||||
BHC | Bausch Health | 1.11 | ||||
SNDL | SNDL | 1.53 | ||||
TLRY | Tilray | 2.22 | ||||
CGC | Canopy Growth | 5.18 | ||||
SHPH | Shuttle Pharmaceuticals | 5.56 |
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |